Developing Molecular biomarkers in sleep disorders


This project will explore potential biomarkers for a range of sleep disorders including obstructive sleep apnoea, insomnia and circadian phase disorders.


Dr Craig Phillips, Professor Ron Grunstein

Research Location

Camperdown - Woolcock Institute of Medical Research

Program Type



Sleep disorders such as sleep apnoea are highly prevalent in the community. Their diagnosis is often time consuming and expensive and their effects on health are often multi-factorial. To date there is a lack of easily deployable cheap tests for detection of sleep disorders, for identification of inter-individual vulnerability to their consequences and inter-individual responses to treatment. This project will explore whether specific sleep disorders can be identified through differential expression of molecular biomarkers that are known to be associated with common disease processes.

Want to find out more?

Contact us to find out what’s involved in applying for a PhD. Domestic students and International students

Contact Research Expert to find out more about participating in this opportunity.

Browse for other opportunities within the Camperdown - Woolcock Institute of Medical Research .


Sleep disturbance, biomarker, circadian, hypoxia

Opportunity ID

The opportunity ID for this research opportunity is: 1121

Other opportunities with Dr Craig Phillips

Other opportunities with Professor Ron Grunstein